Trending Now - Supreme Court to Review Abortion Pill Access Amid Safety Concerns

WHO:

Fox News - Republican lawmakers are involved in the Supreme Court brief regarding mifepristone.

NPR - Justice Samuel Alito is mentioned in relation to the Supreme Court's actions.

NPR - Steve Vladeck, a professor at Georgetown University Law Center, commented on the Department of Justice's position.

NPR - Mary Ziegler, a law professor and abortion historian at the University of California Davis, provided insights on the case.

NPR - Jane, a 44-year-old woman from Florida, shared her personal experience regarding abortion access.

WHAT:

Fox News - A Supreme Court brief was filed alleging that loosened mifepristone rules enabled coercion and safety risks.

NPR - The Supreme Court put a federal appeals court ruling on hold for one week, allowing mifepristone to be prescribed through telemedicine until May 11.

NPR - The FDA's 2023 rule on mifepristone is a key issue in the case.

NPR - The Guttmacher Institute estimated that there were 1.1 million abortions in the U.S. in 2025.

NPR - Louisiana reported 9,000 abortions in 2025.

WHERE:

Fox News - The case involves Louisiana's fight to restore safeguards regarding mifepristone.

NPR - Telemedicine abortion is particularly important in rural areas and states like Louisiana and Florida.

WHEN:

NPR - A federal appeals court ruling was issued on May 1, rolling back telemedicine access to mifepristone.

NPR - The deadline for parties to file briefs was Thursday evening.

NPR - The Supreme Court's stay on the appeals court ruling is effective until May 11.

WHY:

NPR - Louisiana argues that telemedicine access to mifepristone undermines its strict abortion ban.

NPR - The Department of Justice did not file a brief defending the FDA's 2023 rule, raising questions about its position.

HOW:

NPR - The FDA initially required in-person visits to receive mifepristone but changed this policy during the COVID-19 pandemic to allow telemedicine prescriptions.

NPR - The appeals court ruling reinstated the in-person requirement for mifepristone prescriptions nationwide.

(UPDATED May 8, 2026 05:47 UTC)

Republican lawmakers are currently involved in a Supreme Court brief that claims loosened mifepristone rules have led to coercion and safety risks, while the Court has temporarily put a federal appeals court ruling on hold, allowing mifepristone to be prescribed through telemedicine until May 11. The case centers on Louisiana's efforts to restore safeguards regarding mifepristone, as the state argues that telemedicine access undermines its strict abortion ban, and the Department of Justice has not filed a brief to defend the FDA's 2023 rule on the drug. Notably, the appeals court ruling issued on May 1 reinstated the requirement for in-person visits to obtain mifepristone, reversing the previous policy that allowed for telemedicine prescriptions established during the COVID-19 pandemic.